|
NL130088C
(https=)
|
1960-03-14 |
|
|
|
|
GB9420763D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
Acetamide derivatives
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
US6762180B1
(en)
|
1999-10-13 |
2004-07-13 |
Boehringer Ingelheim Pharma Kg |
Substituted indolines which inhibit receptor tyrosine kinases
|
|
AU7961300A
(en)
|
1999-10-29 |
2001-05-14 |
Yamanouchi Pharmaceutical Co., Ltd. |
Kainic acid neurocytotoxicity inhibitors
|
|
AU2001262185A1
(en)
|
2000-04-10 |
2001-10-23 |
Novartis Ag |
Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
|
|
WO2002062389A1
(en)
|
2001-02-08 |
2002-08-15 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary diseases comprising lpa receptor controlling agents
|
|
US7435824B2
(en)
|
2002-04-19 |
2008-10-14 |
Bristol-Myers Squibb Company |
Prodrugs of potassium channel inhibitors
|
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
DE10233500A1
(de)
|
2002-07-24 |
2004-02-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
|
|
US20040204458A1
(en)
|
2002-08-16 |
2004-10-14 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Use of Lck inhibitors for treatment of immunologic diseases
|
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2005023761A2
(en)
|
2003-09-11 |
2005-03-17 |
Kemia, Inc. |
Cytokine inhibitors
|
|
JPWO2005037269A1
(ja)
|
2003-10-21 |
2006-12-28 |
住友製薬株式会社 |
新規ピペリジン誘導体
|
|
EP1687296A1
(en)
|
2003-11-18 |
2006-08-09 |
Warner-Lambert Company LLC |
Antibacterial aminoquinazolidinedione derivatives
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
WO2006091862A2
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Cytokine inhibitors and their use in therapy
|
|
CN101198590B
(zh)
|
2005-08-24 |
2012-05-09 |
卫材R&D管理有限公司 |
吡啶衍生物及嘧啶衍生物（3）
|
|
NZ591443A
(en)
|
2005-09-22 |
2013-04-26 |
Intermune Inc |
Granule formation of pirfenidone and pharmaceutically acceptable excipients
|
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
CA2691214A1
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
JP5164510B2
(ja)
|
2006-10-06 |
2013-03-21 |
日本曹達株式会社 |
含窒素複素環化合物および有害生物防除剤
|
|
WO2008115281A2
(en)
|
2006-10-16 |
2008-09-25 |
Myriad Genetics, Inc. |
Compounds for treating viral infections
|
|
EP2471534A1
(en)
|
2006-12-18 |
2012-07-04 |
Intermune, Inc. |
Method of providing pirfenidone therapy to a patient
|
|
EP2212322B1
(en)
|
2007-10-18 |
2012-04-04 |
Merck Sharp & Dohme Corp. |
Quinolizidinone m1 receptor positive allosteric modulators
|
|
HUE029767T2
(en)
*
|
2008-03-11 |
2017-04-28 |
Incyte Holdings Corp |
JAK inhibitor azetidine and cyclobutane derivatives
|
|
AU2009239500B2
(en)
|
2008-04-21 |
2014-01-30 |
Lexicon Pharmaceuticals, Inc. |
LIMK2 inhibitors, compositions comprising them, and methods of their use
|
|
PT2303270T
(pt)
|
2008-05-05 |
2017-08-25 |
Sanofi Sa |
Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
|
|
UA104590C2
(ru)
|
2008-06-06 |
2014-02-25 |
Берингер Ингельхайм Интернациональ Гмбх |
Капсулированная лекарственная форма, содержащая суспензионную композицию производной индолинона
|
|
US20170065529A1
(en)
|
2015-09-09 |
2017-03-09 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical dosage form for immediate release of an indolinone derivative
|
|
UY32072A
(es)
|
2008-08-26 |
2010-03-26 |
Boehringer Ingelheim Int |
Tienopirimidinas para composiciones farmacéuticas
|
|
US7635707B1
(en)
|
2008-11-10 |
2009-12-22 |
Intermune, Inc. |
Pirfenidone treatment for patients with atypical liver function
|
|
US7566729B1
(en)
|
2008-11-10 |
2009-07-28 |
Intermune, Inc. |
Modifying pirfenidone treatment for patients with atypical liver function
|
|
GB2470833B
(en)
|
2009-06-03 |
2011-06-01 |
Amira Pharmaceuticals Inc |
Polycyclic antagonists of lysophosphatidic acid receptors
|
|
KR101678255B1
(ko)
|
2009-09-25 |
2016-11-21 |
아스텔라스세이야쿠 가부시키가이샤 |
치환 아미드 화합물
|
|
US7816383B1
(en)
|
2009-12-04 |
2010-10-19 |
Intermune, Inc. |
Methods of administering pirfenidone therapy
|
|
US8084475B2
(en)
|
2009-12-04 |
2011-12-27 |
Intermune, Inc. |
Pirfenidone therapy and inducers of cytochrome P450
|
|
ES2682303T3
(es)
|
2010-08-05 |
2018-09-19 |
Zoetis Services Llc |
Derivados de isoxazolina como agentes antiparasitarios
|
|
TW201305178A
(zh)
|
2010-10-29 |
2013-02-01 |
Glenmark Pharmaceuticals Sa |
作為ｍＰＧＥＳ－１抑制物的三環化合物
|
|
DK2648726T3
(da)
|
2010-12-07 |
2018-07-16 |
Amira Pharmaceuticals Inc |
Polycyklisk lpa1-antagonist og anvendelser deraf
|
|
JP6097998B2
(ja)
|
2010-12-16 |
2017-03-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロイコトリエン生成のビアリールアミドインヒビター
|
|
PH12013501831B1
(en)
|
2011-03-10 |
2019-06-14 |
Zoetis Services Llc |
Spirocyclic isoxazoline derivatives as antiparasitic agents
|
|
CA2835438A1
(en)
|
2011-05-25 |
2012-11-29 |
Intermune, Inc. |
Pirfenidone and anti-fibrotic therapy in selected patients
|
|
JP2014525932A
(ja)
*
|
2011-08-15 |
2014-10-02 |
インターミューン， インコーポレイテッド |
リゾホスファチド酸レセプターアンタゴニスト
|
|
CA2859965A1
(en)
|
2011-12-21 |
2013-06-27 |
Ardelyx, Inc. |
Non-systemic tgr5 agonists
|
|
CA2819967C
(en)
|
2012-08-31 |
2016-03-22 |
Intermune, Inc. |
Use of pirfenidone concomitantly with ciprofloxacin
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
WO2014079805A1
(en)
|
2012-11-23 |
2014-05-30 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds for treating hairloss
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
AR108185A1
(es)
|
2016-04-06 |
2018-07-25 |
Abbvie Inc |
Amidas terciarias y método para su uso
|
|
WO2017207643A1
(en)
|
2016-06-01 |
2017-12-07 |
Boehringer Ingelheim International Gmbh |
Use of ecm biomarkers for the determining the treatment onset with nintedanib and pirfenidone
|
|
CN112105616B
(zh)
|
2018-02-02 |
2023-09-01 |
基因技术公司 |
药学化合物、其盐类、其制剂和其制备和使用方法
|
|
US11345678B2
(en)
*
|
2018-04-18 |
2022-05-31 |
Medshine Discovery Inc. |
Benzopyrazole compound used as RHO kinase inhibitor
|
|
PT3802517T
(pt)
|
2018-06-07 |
2023-03-20 |
Idorsia Pharmaceuticals Ltd |
Derivados de piridinilo substituídos por alcoxi como antagonistas do recetor de lpa1 e a sua utilização no tratamento da fibrose
|
|
AR119162A1
(es)
|
2019-06-18 |
2021-12-01 |
Idorsia Pharmaceuticals Ltd |
Derivados de piridin-3-ilo
|